Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)

SHA:603439 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,129	5,205	7,738	5,637	6,483	8,252
Market Cap Growth	-21.57%	-32.74%	37.27%	-13.05%	-21.44%	-
Enterprise Value	5,519	5,445	7,421	5,342	6,161	7,991
Last Close Price	12.76	12.63	18.08	13.06	15.03	18.98
PE Ratio	20.31	18.99	26.44	28.01	42.58	87.84
Forward PE	-	13.81	26.53	25.89	-	-
PS Ratio	2.41	2.43	4.73	4.69	6.91	13.09
PB Ratio	3.13	3.26	4.53	4.55	6.28	8.40
P/TBV Ratio	6.36	6.88	11.37	5.81	6.41	8.51
P/FCF Ratio	113.24	84.12	46.07	32.51	50.27	715.14
P/OCF Ratio	59.72	48.61	27.97	19.22	41.82	130.48
EV/Sales Ratio	2.59	2.54	4.54	4.45	6.56	12.68
EV/EBITDA Ratio	14.15	13.54	24.44	24.24	37.78	70.73
EV/EBIT Ratio	18.05	16.58	27.77	26.11	40.56	76.20
EV/FCF Ratio	121.86	88.00	44.18	30.81	47.77	692.48
Debt / Equity Ratio	0.45	0.38	0.33	0.17	0.19	0.20
Debt / EBITDA Ratio	1.90	1.50	1.83	0.93	1.23	1.77
Debt / FCF Ratio	16.37	9.81	3.30	1.19	1.55	17.33
Asset Turnover	0.70	0.70	0.69	0.75	0.71	0.63
Inventory Turnover	2.29	2.63	3.20	3.64	4.07	4.14
Quick Ratio	1.17	1.16	1.56	1.94	2.79	3.30
Current Ratio	1.51	1.46	1.78	2.14	3.05	3.49
Return on Equity (ROE)	15.47%	16.94%	20.01%	16.91%	14.76%	11.51%
Return on Assets (ROA)	6.27%	6.71%	7.05%	7.94%	7.13%	6.59%
Return on Capital (ROIC)	8.08%	9.19%	9.01%	9.56%	7.87%	7.15%
Return on Capital Employed (ROCE)	15.30%	16.80%	12.80%	16.10%	14.50%	10.50%
Earnings Yield	5.07%	5.27%	3.78%	3.57%	2.35%	1.14%
FCF Yield	0.88%	1.19%	2.17%	3.08%	1.99%	0.14%
Dividend Yield	2.63%	2.69%	1.11%	0.77%	-	1.32%
Payout Ratio	39.84%	37.97%	17.40%	4.43%	72.37%	-
Buyback Yield / Dilution	-1.74%	0.79%	-0.36%	0.19%	-5.14%	-5.90%
Total Shareholder Return	0.89%	3.48%	0.75%	0.96%	-5.14%	-4.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.